This transgene consists of the human nestin second intron enhancer joined to a basic thymidine kinase promoter and the human PDGFB cDNA (without the 5' and 3' untranslated regions) followed by an internal ribosomal entry site (IRES) and a lacZ reporter gene. The minimal nestin enhancer element is specific for embryonic expression but will not drive adult expression of PDGF-B. Three lines were made: 310, 312, and 319. Beta-galactosidase assays show that the transgene is expressed in the developing CNS, with high expression at E10.5, limited expression at E17.5 and no expression at P0. In the retina, transgene expression commences on E17.5 and attains maximal level between P1 and P15, before declining on P20. (J:165035)
查看原文 参与反馈

基础信息

模型ID
品系来源
等位基因类型
突变
遗传方式
基因表达
相关疾病
参考文献
(C57BL/6 x CBA)F2
--
Insertion
--
1
--
2

表型特征

标签摘要:
hm: 纯合子
ht: 杂合子
cn: 条件基因型
cx: 复合型:涉及多基因组
tg: 转基因
ot: 其他:半合子、不确定...
(F): 雌性
(M): 雄性
观察到的表型
N: 正常表型
(#): 上标括号内为相关疾病数量
模型表型:
显示/隐藏列
表型

文献报道

标题
PMID
期刊
年代
IF
暂无数据
Wechat
Comparison
Al agent
Tutorials
Back to top